Literature DB >> 535125

Methodology of data reporting in advanced breast cancer trials.

S K Carter.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 535125     DOI： 10.1007/BF00254413

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  7 in total

1.  Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.

Authors:  J L Hayward; P P Carbone; J C Heuson; S Kumaoka; A Segaloff; R D Rubens
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

2.  Combined cytotoxic and progestogen therapy for advanced breast cancer.

Authors:  R D Rubens; R H Begent; R K Knight; S A Sexton; J L Hayward
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

3.  Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.

Authors:  T Nemoto; D Rosner; R Diaz; T Dao; R Sponzo; T Cunningham; J Horton; R Simon
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

4.  Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study.

Authors:  B Tranum; B Hoogstraten; A Kennedy; C B Vaughn; B Samal; T Thigpen; S Rivkin; F Smith; R L Palmer; J Costanzi; W G Tucker; H Wilson; T R Maloney
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

5.  A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.

Authors:  J M Bull; D C Tormey; S H Li; P P Carbone; G Falkson; J Blom; E Perlin; R Simon
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

6.  Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.

Authors:  H B Muss; D R White; F Richards; M R Cooper; J J Stuart; D V Jackson; L Rhyne; C L Spurr
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

7.  Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.

Authors:  G T Kennealey; B Boston; M S Mitchell; M K Knobf; S N Bobrow; J F Pezzimenti; R Lawrence; J R Bertino
Journal:  Cancer       Date:  1978-07       Impact factor: 6.860
  7 in total
  1 in total

1.  Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.

Authors:  N J Gwavava; C R Pinkerton; J F Glasgow; J M Sloan; J M Bridges
Journal:  J Clin Pathol       Date:  1981-07       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.